Deciphering the Epitranscriptomic Signatures in Cell Fate Determination and Development
- PMID: 31123982
- DOI: 10.1007/s12015-019-09894-3
Deciphering the Epitranscriptomic Signatures in Cell Fate Determination and Development
Abstract
Precise regulation of transcriptome modulates several vital aspects in an organism that includes gene expression, cellular activities and development, and its perturbation ensuing pathological conditions. Around 150 post-transcriptional modifications of RNA have been identified till date, which are evolutionarily conserved and likewise prevalent across RNA classes including messenger RNA (mRNA), transfer RNA (tRNA), ribosomal RNA (rRNA), and detected less frequently in small nuclear RNA (snRNA) and microRNAs (miRNA). Among the RNA modifications documented, N6-methyladenosine (m6A) is the best characterised till date. Also, N1-methyladenosine (m1A), 5-methylcytosine (m5C) and pseudouridine (Ψ) are some of the other prominent modifications detected in coding and non-coding RNAs. "Epitranscriptome", ensemble of these post-transcriptional RNA modifications, precisely coordinates gene expression and biological processes. Current literatures suggest the critical involvement of epitranscriptomics in several organisms during early development, contributing to cell fate specification and physiology. Indeed, epitranscriptomics similar to DNA epigenetics involves combinatorial dynamics provided by modified RNA molecules and associated protein complexes, which function as "writers", "erasers" and "readers" of these modifications. A novel code orchestrating gene expression during cell fate determination is generated by the coordinated effects of different classes of modified RNAs and its regulator proteins. In this review, we summarize the current knowhow on N6-methyladenosine (m6A), 5-methylcytosine (m5C) and pseudouridine (ψ) modifications in RNA, the associated regulator proteins and enumerate how the epitranscriptomic regulations are involved in cell fate determination.
Keywords: Cell fate; Embryonic development; Epitranscriptomics; Post-transcriptional modification; RNA binding protein; Stem cells.
Similar articles
-
The role of m6A, m5C and Ψ RNA modifications in cancer: Novel therapeutic opportunities.Mol Cancer. 2021 Jan 18;20(1):18. doi: 10.1186/s12943-020-01263-w. Mol Cancer. 2021. PMID: 33461542 Free PMC article. Review.
-
The Dark Side of the Epitranscriptome: Chemical Modifications in Long Non-Coding RNAs.Int J Mol Sci. 2017 Nov 10;18(11):2387. doi: 10.3390/ijms18112387. Int J Mol Sci. 2017. PMID: 29125541 Free PMC article. Review.
-
Deciphering the epitranscriptome: A green perspective.J Integr Plant Biol. 2016 Oct;58(10):822-835. doi: 10.1111/jipb.12483. Epub 2016 Jun 20. J Integr Plant Biol. 2016. PMID: 27172004 Free PMC article. Review.
-
The Repertoire of RNA Modifications Orchestrates a Plethora of Cellular Responses.Int J Mol Sci. 2023 Jan 25;24(3):2387. doi: 10.3390/ijms24032387. Int J Mol Sci. 2023. PMID: 36768716 Free PMC article. Review.
-
The epitranscriptome in stem cell biology and neural development.Neurobiol Dis. 2020 Dec;146:105139. doi: 10.1016/j.nbd.2020.105139. Epub 2020 Oct 13. Neurobiol Dis. 2020. PMID: 33065280 Free PMC article. Review.
Cited by
-
Lactylation, an emerging hallmark of metabolic reprogramming: Current progress and open challenges.Front Cell Dev Biol. 2022 Aug 26;10:972020. doi: 10.3389/fcell.2022.972020. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 36092712 Free PMC article. Review.
-
Brown Fat-Activating Lipokine 12,13-diHOME in Human Milk Is Associated With Infant Adiposity.J Clin Endocrinol Metab. 2021 Jan 23;106(2):e943-e956. doi: 10.1210/clinem/dgaa799. J Clin Endocrinol Metab. 2021. PMID: 33135728 Free PMC article.
-
N6-methyladenosine (m6A) as a regulator of carcinogenesis and drug resistance by targeting epithelial-mesenchymal transition and cancer stem cells.Heliyon. 2023 Feb 26;9(3):e14001. doi: 10.1016/j.heliyon.2023.e14001. eCollection 2023 Mar. Heliyon. 2023. PMID: 36915498 Free PMC article. Review.
-
Dysregulation of pseudouridylation in small RNAs contributes to papillary thyroid carcinoma metastasis.Cancer Cell Int. 2024 Oct 14;24(1):337. doi: 10.1186/s12935-024-03482-3. Cancer Cell Int. 2024. PMID: 39402656 Free PMC article.
-
Roles of RNA m5C modification patterns in prognosis and tumor microenvironment infiltration of diffuse large B-cell lymphoma.Am J Cancer Res. 2024 Apr 15;14(4):1768-1783. doi: 10.62347/NXDR1826. eCollection 2024. Am J Cancer Res. 2024. PMID: 38726285 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources